ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,957, issued on Oct. 6, was assigned to TransThera Sciences (Nanjing) Inc. (Nanjing, China).
"Use of multikinase inhibitor" was invented by Peng Peng (Nanjing, China), Xiaoyan Qiang (Nanjing, China) and Frank Wu (Nanjing, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the technical field of medicines, relates to novel use of a multi-kinase inhibitor, and particularly relates to a compound of general formula (I) or a pharmaceutically acceptable salt, a stereoisomer and a crystal form thereof for use in the treatment of biliary tract cancer, a pharmaceutical composition comprising the compound, a method for treatin...